UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (date of earliest event reported) July 9, 2003
VENTANA MEDICAL SYSTEMS, INC.
(Exact name of Registrant as specified in its charter)
| State of Delaware | 000-20931 | 94-2976937 | ||
| (State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
1910 Innovation Park Drive
Tuscon, AZ 85737
(Address of principal executive offices)
(520) 887-2155
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
| Item 7. | Financial Statements and Exhibits |
(c) Exhibits
| ExhibitNo. |
Description | |
| 99.1 |
Press Release, dated as of July 9, 2003 |
| Item 9. | Regulation FD Disclosure (pursuant to Item 12) |
This information, furnished under “Item 9. Regulation FD Disclosure,” is intended to be furnished under “Item 12. Disclosure of Results of Operations and Financial Condition” in accordance with SEC Release No. 33-8216.
On July 9, 2003, Ventana Medical Systems, Inc. issued a press release announcing preliminary second quarter earnings results. A copy of the press release is attached as Exhibit 99.1.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| VENTANA MEDICAL SYSTEMS, INC. | ||
| By: |
/s/ NICHOLAS MALDEN | |
| Nicholas Malden Vice President, Chief Financial Officer and Secretary | ||
Date: July 9, 2003
EXHIBIT INDEX
| Exhibit |
Description | |
| 99.1 | Press release issued by Ventana Medical Systems, Inc. dated July 9, 2003 | |